2026 LCRF | AstraZeneca Research Award on Strategies Using Patient Advocacy to Improve Outcomes in Small Cell Lung Cancer

The overarching theme of the proposals should be centered around using patient advocacy as a tool to develop strategies toward improving outcomes for patients with SCLC.

LCRF encourageד applications on a wide variety of topics related to SCLC, including but not limited to the following:

• Patient-Centric Care Models

• Advanced Screening and Diagnostic Technologies o Create comprehensive survivorship care plans addressing long-term healthcare needs, focusing on follow-up care, monitoring for recurrence, and managing chronic side effects

• Access and Equity

• Technology Integration

• Patient Feedback Mechanisms

Funding: $250,000
Duration: 2 years

Research Authority deadline: 8.7.26

LOI (required) due date: 15.7.26

Full proposal due date: 5.10.26